Manulife (Manufacturers Life Insurance)’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-72,380
Closed -$297K 3254
2022
Q1
$297K Sell
72,380
-19,794
-21% -$71.8K ﹤0.01% 2521
2021
Q4
$329 Sell
92,174
-373
-0.4% -$1.3K ﹤0.01% 2546
2021
Q3
$337K Sell
92,547
-5,714
-6% -$23.1K ﹤0.01% 2579
2021
Q2
$428K Buy
98,261
+1,813
+2% +$7.39K ﹤0.01% 2552
2021
Q1
$396K Sell
96,448
-3,544
-4% -$15.4K ﹤0.01% 2441
2020
Q4
$399K Sell
99,992
-138
-0.1% -$446 ﹤0.01% 2336
2020
Q3
$270K Hold
100,130
﹤0.01% 2365
2020
Q2
$269K Sell
100,130
-4,753
-5% -$13.3K ﹤0.01% 2326
2020
Q1
$248K Buy
104,883
+6,583
+7% +$22.4K ﹤0.01% 2202
2019
Q4
$462K Sell
98,300
-5,343
-5% -$21.9K ﹤0.01% 2094
2019
Q3
$358K Sell
103,643
-425
-0.4% -$1.4K ﹤0.01% 2212
2019
Q2
$342K Buy
104,068
+6,834
+7% +$19.8K ﹤0.01% 2286
2019
Q1
$295K Sell
97,234
-6,778
-7% -$22K ﹤0.01% 2276
2018
Q4
$282K Buy
104,012
+59,525
+134% +$196K ﹤0.01% 2188
2018
Q3
$149K Sell
44,487
-74,220
-63% -$229K ﹤0.01% 2835
2018
Q2
$306K Buy
118,707
+2,764
+2% +$6.88K ﹤0.01% 2770
2018
Q1
$256K Sell
115,943
-2,903
-2% -$6.53K ﹤0.01% 2830
2017
Q4
$237K Sell
118,846
-1,057
-0.9% -$2.3K ﹤0.01% 2876
2017
Q3
$389K Sell
119,903
-1,730
-1% -$5.34K ﹤0.01% 2452
2017
Q2
$392K Buy
121,633
+112,191
+1,188% +$318K ﹤0.01% 2479
2017
Q1
$27K Buy
9,442
+8,287
+717% +$19.9K ﹤0.01% 3481
2016
Q4
$3K Hold
1,155
﹤0.01% 4068
2016
Q3
$2K Hold
1,155
﹤0.01% 4092
2016
Q2
$1K Sell
1,155
-106,206
-99% -$103K ﹤0.01% 4173
2016
Q1
$92K Buy
107,361
+2,971
+3% +$2.88K ﹤0.01% 3084
2015
Q4
$126 Buy
104,390
+300
+0.3% +$418 ﹤0.01% 2985
2015
Q3
$177 Buy
104,090
+2,028
+2% +$3.98K ﹤0.01% 2747
2015
Q2
$213 Buy
102,062
+18,873
+23% +$45.8K ﹤0.01% 2800
2015
Q1
$225 Buy
83,189
+3,105
+4% +$7.88K ﹤0.01% 2647
2014
Q4
$206 Sell
80,084
-484
-0.6% -$1.09K ﹤0.01% 2622
2014
Q3
$147 Buy
80,568
+3,070
+4% +$6.69K ﹤0.01% 2853
2014
Q2
$207K Sell
77,498
-10,756
-12% -$32.4K ﹤0.01% 2688
2014
Q1
$309 Sell
88,254
-785
-0.9% -$3.48K ﹤0.01% 2414
2013
Q4
$399 Sell
89,039
-3,958
-4% -$16.1K ﹤0.01% 2221
2013
Q3
$377 Sell
92,997
-3,416
-4% -$14.9K ﹤0.01% 2176
2013
Q2
$401K Buy
+96,413
New +$372K ﹤0.01% 2037

Other funds holding ATRS

Manulife (Manufacturers Life Insurance)'s ATRS Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 72,380 shares — an estimated $297K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $462K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 72,380 Antares Pharma, Inc. shares in Q2 2022, an estimated $297K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
  • Manulife (Manufacturers Life Insurance)'s Antares Pharma, Inc. position peaked at $462K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.